Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
about
Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt SignallingMeningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngiomaAmeloblastoma: A Review of Recent Molecular Pathogenetic DiscoveriesA diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.Exome sequencing identifies BRAF mutations in papillary craniopharyngiomasFirst insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosisWhole-genome sequencing identifies new genetic alterations in meningiomasA novel mutation of the FAT2 gene in spinal meningioma.Multiple Meningiomas in a Patient with Cowden Syndrome.Smoothened goes molecular: new pieces in the hedgehog signaling puzzleMolecular Testing of Brain Tumor.Genomic profile of human meningioma cell lines.The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.Smoothened gene alterations in keratocystic odontogenic tumors.Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1Prospective enterprise-level molecular genotyping of a cohort of cancer patients.Global expression profile in low grade meningiomas and schwannomas shows upregulation of PDGFD, CDH1 and SLIT2 compared to their healthy tissue.Molecular Targets and Treatment of Meningioma.PET Imaging in Patients with Meningioma - Report of the RANO/PET Group.Sporadic hemangioblastomas are characterized by cryptic VHL inactivation.Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningiomaPhase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-MakingGroup I Paks as therapeutic targets in NF2-deficient meningioma.BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers.CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaGenetic/molecular alterations of meningiomas and the signaling pathways targeted.Pathology and molecular genetics of meningioma: recent advances.Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity.Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaTERT Promoter Mutations and Risk of Recurrence in Meningioma.Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
P2860
Q26739662-2031C522-74AC-4ECA-891C-035F4850F489Q26741529-E763B713-467C-4147-B608-3461B7824986Q26777288-77874231-946D-4BC6-B96D-70902BE20C83Q26781648-E546BC70-7687-409D-A2AD-0D3166FE13FAQ27852958-3CCF0E09-12D1-4778-A75A-4B515F8034EFQ27853347-ADA0ED74-F846-4F6F-A732-F9F02FE8D5E5Q28305680-BC121D6A-71FD-4D0C-9C63-474E12C320D6Q30274790-65333710-28B2-420B-8501-180B40F54017Q30357776-108FE4BE-9BBA-4DA9-89A2-BD5BDFE0E6B6Q30358577-58D4F31E-17E0-41F3-8749-FFFD126CC72FQ30369056-A2E24BC8-589F-4E51-B1A0-20E8A5156951Q30375908-E1B14A2E-60B1-48E6-B2D8-EDE734E1AF8AQ33359720-4D153F65-A082-4B48-A13F-494A821500C3Q33729693-8D399945-FC46-495F-9AFE-4371E6B45C1EQ33731952-CC31C68B-6E86-41DB-B154-ACA337690C00Q33799070-2E024D1C-8EAE-4ED9-B087-BB43DE7B964AQ34196922-71184E00-2617-49CE-B4AA-F9763B7C682FQ34342166-60860DA4-51E9-4BB0-B6A9-14FFDF8BD8E7Q34409739-8FCC3898-F78F-4668-9AF3-EDBDE9614181Q34556785-23BF1C01-F0C4-4BAC-AF12-D05E92C1807CQ34631513-6402C167-68E2-4712-83AA-B7075F592175Q34682187-0259DC38-0B63-43A2-A975-42B44132CB06Q34979062-AB989B92-8AD7-479E-9EFE-AAE2F65EFC09Q35072568-5C38A42C-D2B3-46F0-937F-D2074A73EB27Q35106253-4D0F0FE0-8F4F-448A-8951-1CB30BA08D0FQ35232689-D48B2858-3E47-47F5-85F3-A73D7FF77F1FQ35273319-A27CB272-B7D0-423F-AF1E-0ABF820AAF87Q35453542-A894AEAD-604D-4E22-9DFA-4DEC642D06ACQ35691269-1CC368D1-DB5C-4B70-9322-F37BE39F0F2EQ35741539-110801D3-D546-417A-A62F-6530FF945D51Q35793582-8C9BDF05-8D40-4BB2-99FF-D676743B1D88Q35943650-93FE7587-14DB-4B54-883A-8358DBDE4795Q36228558-EA783B4F-7857-4EEE-B3E2-9B7111E8379BQ36346636-65461713-09BB-4F08-A9C2-32A08BE4CEB6Q36483721-95E37134-DCB1-4D12-9921-2D4A9E452588Q36618268-FD2E302C-031C-42C3-9A02-E8F331AB1D52Q36785144-A866B508-5C8D-443A-82DB-E701A40509A9Q36849156-F687B62B-32B9-4C11-82E2-747DEF5142ACQ36859396-53A062CC-0D32-41E0-9049-569BC9E33DB6Q36876967-4378FDD1-32D7-4215-8092-984A02A745A2
P2860
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@en
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@nl
type
label
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@en
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@nl
prefLabel
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@en
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@nl
P2093
P2860
P50
P356
P1433
P1476
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
@en
P2093
Aaron McKenna
Alina Raza
Anat O Stemmer-Rachamimov
Ashwini Sunkavalli
David N Louis
Emanuele Palescandolo
Ian F Dunn
Keith L Ligon
Laura E Macconaill
Matthew D Ducar
P2860
P2888
P304
P356
10.1038/NG.2526
P407
P577
2013-01-20T00:00:00Z
P5875
P6179
1031333121